Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$1,057.02 5.99 (0.57%) as of 4:30 Mon 7/1


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 110.66(B)
Last Volume: 383,195 Avg Vol: 759,306
52 Week Range: $692.45 - $1071.19
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 192,108 255,165 311,759 469,743
Total Sell Value $188,697,290 $247,812,013 $294,950,701 $405,465,351
Total People Sold 7 14 16 18
Total Sell Transactions 18 43 67 128
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 2430
  Page 56 of 98  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Brown Michael S Director   –       •      –    2014-07-30 4 A $0.00 $0 D/D 5,687 5,687     -
   Brown Michael S Director   –       •      –    2014-07-17 4 GA $0.00 $0 I/I 14,662 14,662     -
   Brown Michael S Director   –       •      –    2014-07-17 4 GD $0.00 $0 D/D 14,662 0     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-07-15 4 AB $310.18 $40,656,176 I/I 129,100 22,204,841     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-07-14 4 AB $314.52 $47,726,797 I/I 150,000 22,075,741     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-07-11 4 AB $311.39 $47,311,836 I/I 150,000 21,925,741     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-07-10 4 AB $306.77 $54,439,073 I/I 175,000 21,775,741     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-07-09 4 AB $304.19 $60,112,311 I/I 195,000 21,600,741     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-07-08 4 AB $309.33 $47,685,743 I/I 153,000 21,405,741     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-07-07 4 AB $311.17 $80,320,795 I/I 256,700 21,252,741     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-07-03 4 AB $309.46 $31,101,946 I/I 100,000 20,996,041     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-07-02 4 AB $298.91 $65,259,552 I/I 212,400 20,896,041     -
   Vagelos P Roy Chairman of the Board   •       •      –    2014-07-01 4 GD $0.00 $0 I/I 756 156,368     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-07-01 4 AB $285.89 $63,761,421 I/I 212,400 20,683,641     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-06-30 4 AB $275.68 $60,010,479 I/I 212,400 20,471,241     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-06-27 4 AB $272.70 $13,769,092 I/I 50,000 20,258,841     -
   Van Plew Daniel P SVP & General Mgr Industrial O   •       –      –    2014-05-23 4 S $295.33 $1,588,872 D/D (5,369) 15,441     -
   Van Plew Daniel P SVP & General Mgr Industrial O   •       –      –    2014-05-22 4 D $296.19 $1,727,084 D/D (5,831) 20,810     -
   Van Plew Daniel P SVP & General Mgr Industrial O   •       –      –    2014-05-22 4 OE $21.25 $238,000 D/D 11,200 26,641     -
   Poon Christine A Director   –       •      –    2014-05-21 4 B $291.90 $74,435 D/D 255 255 2.39     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-05-19 4 B $296.08 $57,233,716 I/I 190,751 20,208,841 1.5     -
   Ryan Arthur F Director   –       •      –    2014-05-16 4 GD $0.00 $0 D/D 2,355 47,500     -
   Vagelos P Roy Chairman of the Board   •       •      –    2014-04-01 4 GD $0.00 $0 I/I 700 157,124     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-03-28 4 B $300.28 $94,149,583 I/I 306,945 20,018,090 1.5     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-03-27 4 B $302.96 $95,463,963 I/I 306,945 19,711,145 1.5     -
  2430 Records found
  Previous  50  51  52  53  54  55  56  57  58  59  Next   
  Page 56 of 98
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us